Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 24;29(6):3807-3824.
doi: 10.3390/curroncol29060305.

Patient Perceived Financial Burden in Haematological Malignancies: A Systematic Review

Catriona Parker  1   2 , Danielle Berkovic  1 , Darshini Ayton  1 , Ella Zomer  1 , Danny Liew  1 , Andrew Wei  2
Affiliations

Patient Perceived Financial Burden in Haematological Malignancies: A Systematic Review

Catriona Parker et al. Curr Oncol. .

Abstract

Advances in scientific understanding have led to novel therapies and improved supportive care for many patients with haematological malignancies. However, these new drugs are often costly, only available at centralised health care facilities, require regular specialist reviews and lengthy treatment regimens. This leads to a significant financial burden. Understanding the impact of financial burden on haematological patients is important to appreciate the urgency of alleviating this systemic issue.

Method: Eligible studies were identified by systematically searching Medline, PsycINFO, CINAHL and Embase. Self-reported data reported in both quantitative and qualitative studies that described the financial burden for patients with haematological malignancies were included. Quality appraisal of the included studies was undertaken using the Joanna Briggs Institute tools. A narrative synthesis was employed. For quantitative studies, outcomes were extracted, tabulated and categorised to find similarities and differences between the studies. For qualitative studies, quotations, codes and themes were extracted and then clustered. An inductive approach derived qualitative themes.

Results: Twenty studies were identified for inclusion. Of the quantitative studies most (83%) employed un-validated researcher-generated measures to assess financial burden. Between 15-59% of patients experienced a financial burden. Out-of-pocket expenditure was frequent for clinical appointments, prescription and non-prescription medication, and travel. Financial burden was associated with a worsening quality of life and living in metropolitan areas, but there was no evidence for impact on survival. Patient-centred experiences from the qualitative inquiry complemented the quantitative findings and five themes were determined: familial or household impact; reliance on others; barriers to care due to cost; and barriers to accessing financial assistance and sources of out-of-pocket expenses.

Conclusion: The impacts of financial burden are yet to be fully appreciated in haematological malignancies, exacerbated by the heterogeneous methods employed by researchers. Future work should focus on identifying the long-term ramifications of financial burden for patients and should trial interventions to reduce its prevalence and patient impacts.

Keywords: economic; financial burden; haematology; leukaemia; lymphoma; multiple myeloma; systematic review.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Preferred Reporting Items for Systematic Reviews and Meta-Analysis diagram.
See this image and copyright information in PMC

References

    1. Tietsche de Moraes Hungria V., Chiattone C., Pavlovsky M., Abenoza L.M., Agreda G.P., Armenta J., Arrais C., Flores O.A., Barroso F., Basquiera A.L., et al. Epidemiology of Hematologic Malignancies in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study. J. Glob. Oncol. 2019;5:1–19. doi: 10.1200/JGO.19.00025. - DOI - PMC - PubMed
    1. Dohner H., Estey E.H., Amadori S., Appelbaum F.R., Buchner T., Burnett A.K., Dombret H., Fenaux P., Grimwade D., Larson R.A., et al. Diagnosis and management of acute myeloid leukemia in adults: Recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115:453–474. doi: 10.1182/blood-2009-07-235358. - DOI - PubMed
    1. Altice C.K., Banegas M.P., Tucker-Seeley R.D., Yabroff K.R. Financial Hardships Experienced by Cancer Survivors: A Systematic Review. J. Natl. Cancer Inst. 2017;109:djw205. doi: 10.1093/jnci/djw205. - DOI - PMC - PubMed
    1. Zafar S.Y., Abernethy A.P. Financial Toxicity, Part I: A New Name for a Growing Problem. Oncology. 2013;27:80–149. - PMC - PubMed
    1. Gordon L., Merollini K.M.D., Lowe A., Chan R.J. A Systematic Review of Financial Toxicity Among Cancer Survivors: We Can’t Pay the Co-Pay. Patient—Patient-Cent. Outcomes Res. 2017;10:295–309. doi: 10.1007/s40271-016-0204-x. - DOI - PubMed

Publication types

LinkOut - more resources